Dasolampanel
id:
dasolampanel-322-2582631
title:
Dasolampanel
text:
Dasolampanel is an orally bioavailable analog of tezampanel and thereby competitive antagonist of the AMPA and kainate receptors which was under development by Raptor Pharmaceuticals/Torrey Pines Therapeutics for the treatment of chronic pain conditions including neuropathic pain and migraine. It was developed as a follow-on compound to tezampanel, as tezampanel is not bioavailable orally and must be administered by intravenous injection, but ultimately neither drug was ever marketed.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Dasolampanel
date created:
date modified:
2024-01-09T02:28:56Z
main entity:
{"identifier":"Q19596736","url":"https://www.wikidata.org/entity/Q19596736"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/a/a3/Dasolampanel.svg","width":1480,"height":895}
fields total:
13
integrity:
15